MedPath

COVID-19 pandemic impact on severe asthma patients care in Europe

Conditions
Severe asthma
Registration Number
NL-OMON24123
Lead Sponsor
SHARP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
900
Inclusion Criteria

patients with physician diagnosed severe asthma who are followed up in an asthma clinic for at least 6 months at the beginning of the COVID-19 pandemic

Exclusion Criteria

none

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath